Cannabis
It found that patients' agitation was reduced by 30% on average after taking a tablet with the artificial cannabinoid
Hi, what are you looking for?
Mugglehead Investment Magazine
All posts tagged "Johns Hopkins University"
Canada
Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy
Medical and Pharmaceutical
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine
Psychedelics
A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound
The weed wire
The new hub will focus on the rapidly advancing field by adding unique public education and spiritual components
The weed wire
Funded by research non-profit Unlimited Sciences, the study aims to expand knowledge of real-world use of psilocybin
Psychedelics
Extracting psilocybin from magic mushrooms will be cheaper than current method of creating synthetic compound for research, says company
Analysis
Research, therapeutic and medical drug development and investment can all flourish under pre-existing legal pathways, experts say
